Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
05 February 2021
Closing Date:
30 December 2022
Location(s):
DE DEUTSCHLAND (DE Germany/DEUTSCHLAND)
Description:
Contrast media - cross-active ingredient open-house procedure for the KV region Schleswig-Holstein

The subject of this publication is the conclusion of non-exclusive agreements on various contrast agent active ingredients / active ingredient combinations within the framework of an open-house procedure, which are prescribed and issued in the SSB at the expense of the health insurance companies in Schleswig-Holstein. More details on the active substances concerned can be found in the division into specialist groups (Appendix 5 to this publication). Contrast media of each future contract partner can be ordered for a specialist group during the contract period due to the economic efficiency requirement by the contract doctors, who are informed about these economic sources of supply; they are considered economical. Contract doctors are obliged to meet their need for contrast media from a specialist group with the products of the contract partner or one of the contract partners. For each specialist group there is a fixed, non-negotiable contract price for the duration of the contract.

Section G

Description: Non-ionic iodine-containing monomeric, low-osmolar, water-soluble nephrotropic X-ray contrast media

Application: intra-arterial and intravenous and intracavity. More possible.

Application areas:

- urography,

- venography,

- CT contrast enhancement,

- digital subtraction angiography (DSA).

Active ingredients / combinations (ATC): Iohexol (V08AB02) and / or Iopamidol (V08AB04) and / or Iopromide (V08AB05) and / or Iomeprol (V08AB10) and / or Iobitridol (V08AB11) and / or Ioversol (V08AB07) and / or more possible

Dosage forms: all approved dosage forms of an active ingredient must be offered.

Concentration: 150 mg / ml - 250 mg / ml, all concentrations of an active ingredient must be offered.

Pack size: all approved pack sizes of an active substance must be offered.

Further information can be found in Appendix 5 to the request for quotation.

Section S

Name: ultrasound contrast medium

Application: Intravenous use

Areas of application: echocardiography, Doppler sonography (macro and microvasculature), ultrasound of the lower urinary tract

Active ingredients / combinations (ATC): Sulfur hexafluoride (V08DA05)

Dosage form: all dosage forms of the active ingredient

Concentration: all concentrations possible

Pack size: All pack sizes of the active ingredient.

Further information can be found in Appendix 5 to the request for quotation.

Section H

Description: Non-ionic iodine-containing dimeric, low-osmolar, water-soluble nephrotropic X-ray contrast media.

Application: intra-arterial and intravenous. More possible.

Application areas:

- Cerebral angiography, abdominal angiography, peripheral arteriography, venography,

- urography,

- Contrast enhancement in computed tomography (CT).

Active ingredients / combinations (ATC): Iodixanol (V08AB09) and / or others possible.

Dosage forms: all approved dosage forms of an active ingredient must be offered.

Concentrations must be offered cumulatively:

1. 270 mg / ml (all concentrations of an active ingredient must be offered),

2. 320 mg / ml (all concentrations of an active substance must be offered).

(at least all areas of application must be covered together).

Pack size: all approved pack sizes of an active substance must be offered.

Further information can be found in Appendix 5 to the request for quotation.

Section J

Name: Paramagnetic extracellular linear contrast media for MRI.

Application: Intra-articular application.

Areas of application: Direct magnetic resonance arthrography.

NSF risk: high NSF risk class.

Active ingredients / combinations (ATC): gadopentetic acid (V08CA01).

Dosage forms: All dosage forms of the active ingredient for this indication.

Concentration: 0.002 mmol / ml.

Pack size: All pack sizes of the active ingredient for this indication.

Further information can be found in Appendix 5 to the request for quotation.

Section M

Name: Paramagnetic extracellular macrocyclic contrast media for MRI.

Application: Intra-articular application.

Areas of application: Direct magnetic resonance arthrography.

NSF risk: Low NSF risk class.

Active ingredients / combinations (ATC): Gadoteric acid (V08CA02).

Dosage forms: All dosage forms of the active ingredient for this indication.

Concentration: 0.0025 mmol / ml.

Pack size: All pack sizes of the active ingredient for this indication.

Further information can be found in Appendix 5 to the request for quotation.

Section N

Name: Paramagnetic extracellular linear contrast media for MRI with renal excretion and partial biliary excretion.

Application: Intravenous. More possible.

Areas of application: MRI of the liver.

NSF risk: Medium NSF risk class.

Active ingredients / combinations (ATC): gadobenic acid (V08CA08).

Dosage forms: All approved dosage forms of an active ingredient.

Concentration: All concentrations possible.

Pack size: All approved pack sizes of the active ingredient.

Further information can be found in Appendix 5 to the request for quotation.

Section O

Name: Paramagnetic combines extracellular and hepatobiliary linear contrast media for MRI (excretion 50-50).

Application: Intravenous use. More possible.

Areas of application: MRI of the liver.

NSF risk: Medium NSF risk class.

Active ingredients / combinations (ATC): Gadoxetic acid (V08CA10).

Dosage forms: All dosage forms of the active ingredient.

Concentration: All concentrations possible.

Pack size: All pack sizes of the active ingredient.

Further information can be found in Appendix 5 to the request for quotation.

Section P

Description: Contrast media containing barium sulphate.

Application: Oral and / or intestinal and / or rectal use.

Areas of application: Representation of parts of the digestive tract and / or the entire digestive tract by CT and / or X-ray, others are possible.

Active ingredients / combinations (ATC): Barium sulfate (V08BA).

Dosage forms: All dosage forms of the active ingredient.

Concentration: All concentrations possible.

Pack size: All pack sizes of the active ingredient.

Further information can be found in Appendix 5 to the request for quotation.

Section Q

Name: ultrasound contrast medium

Application: Intravenous use

Areas of application: echocardiography, others possible

Active ingredients / combinations (ATC): Phospholipid microspheres, containing perflutren (V08DA04)

Dosage form: all dosage forms of the active ingredient

Concentration: all concentrations possible

Pack size: all pack sizes of the active ingredient

Further information can be found in Appendix 5 to the request for quotation

Section R

Name: ultrasound contrast medium

Application: Intravenous use

Areas of application: echocardiography, others possible

Active ingredients / combinations (ATC): Albumin microspheres, containing perflutren (V08DA01)

Dosage form: all dosage forms of the active ingredient

Concentration: all concentrations possible

Pack size: All pack sizes of the active ingredient.

Further information can be found in Appendix 5 to the request for quotation.

Download full details as .pdf
The Buyer:
Der AOK-Bundesverband führt im Namen der in der Bekanntmachung genannten Auftraggeberinnen das Vergabeverfahren durch.
CPV Code(s):
33600000 - Pharmaceutical products
33696000 - Reagents and contrast media
33696800 - X-ray contrast media